Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists

Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists

US Patent 8207193 · Granted Jun 26, 2012

Estimated economic value: $6,535,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydropyridopyrimidine derivatives as AhR modulators2025
Potassium channel inhibitors2024
Potassium channel inhibitors2024
Potassium channel inhibitors2022
Potassium channel inhibitors2021
Potassium channel inhibitors2021
Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one2018
Cyclic depsipeptide compounds and their uses2018
Cyclic depsipeptide compounds and their uses2016
Quinuclidine derivatives as muscarinic M3 receptor antagonists2012
Quinuclidine derivatives as muscarinic M3 receptor antagonists2012
Substituted 1-cyanoethylheterocyclylcarboxamide compounds2012